Who Owns PCSA?

Processa Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$2.92

-0.07 (-2.18%)

Market Cap

$6.3M

Shares Outstanding

2,265,768

Institutional Holders

9

Total Inst. Value

$62K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

2

Closed Positions

2

Increased

3

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLCNew$21K56,000
2Virtu Financial LLCNew$16K43,229
3GEODE CAPITAL MANAGEMENT, LLC$12K34,413
4VANGUARD GROUP INC$9K24,433
5Composition Wealth, LLC$4K10,000
6Tower Research Capital LLC (TRC)$9132,467
7WELLS FARGO & COMPANY/MN$57154
8UBS Group AG$2156
9BANK OF AMERICA CORP /DE/$037

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
UBS Group AG-8K$21

Related Stocks

Frequently Asked Questions

How many institutional investors hold PCSA?

As of Q1 2025, 9 institutional investors report holding PCSA (Processa Pharmaceuticals, Inc.) in their 13F filings.

Which hedge fund owns the most PCSA?

The largest institutional holder of PCSA is ARMISTICE CAPITAL, LLC with $21K in shares.

Are institutions buying or selling PCSA?

This quarter, 2 institutions opened new positions in PCSA and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.